Change search criteria ↓

Search results

348 projects found matching your search criteria:

  1. 101. Structure optimization of inhibitor for paracaspase MALT1

    Principal investigator: dr Paulina Maria Kasperkiewicz

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 6, Panel: ST5

  2. 102. Sensitization of cancer cells to chemotherapy by novel DNA repair inhibitors

    Principal investigator: dr hab. Tomasz Popławski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 6, Panel: NZ7

  3. 103. Novel peptide inhibitors of dipeptidyl peptidase IV (DPP IV) as novel approach for diabetes type 2 and inflammatory bowe…

    Principal investigator: Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 6, Panel: NZ7

  4. 104. Mechanism regulating vitamin D analog cooperation with cytostatics and tyrosine kinase inhibitors in non-small cell lung…

    Principal investigator: dr Ewa Agnieszka Maj

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 5, Panel: NZ4

  5. 105. Design and synthesis of acylpeptide hydrolase inhibitors as potential inducers of apoptosis in tumor cells

    Principal investigator: Maciej Sławomir Walczak

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 5, Panel: ST5

  6. 106. Design and synthesis of selective and irreversible inhibitors of HAT protease.

    Principal investigator: Marcin Skoreński

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 5, Panel: ST5

  7. 107. Phosphonic inhibitors of human neutrophil elastase in cancer therapy

    Principal investigator: dr Łukasz Winiarski

    Politechnika Wrocławska, Wydział Chemiczny

    Call: SONATA 5, Panel: NZ4

  8. 108. Assessment of mechanisms of tumour necrosis factor alpha (TNF-alpha) inhibitors' action in rheumatoid arthritis female p…

    Principal investigator: Anna Iwona Szeremeta

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: PRELUDIUM 5, Panel: NZ5

  9. 109. One-pot synthesis of O-2-isocepham and N-2-isocepham derivatives bearing retroamide/thioretroamide or phosphono/thiophos…

    Principal investigator: Marta Leokadia Schielmann

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 4, Panel: NZ7

  10. 110. New chemical and biological properties of topoizomeraze I inhibitors alkylating DNA oligomers

    Principal investigator: prof. Lech Jan Kozerski

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: OPUS 4, Panel: ST4

  11. 111. Structure - activity relationship studies of new flavonoids derivatives as the inhibitors of the bacterial tyrosyl-tRNA …

    Principal investigator: dr Mirosława Anna Skupińska

    Instytut Chemii Bioorganicznej PAN

    Call: PRELUDIUM 3, Panel: NZ7

  12. 112. Organometallic inhibitors of tubulin polymerisation. Synthesis, anticancer activities and tubulin affinities.

    Principal investigator: dr hab. Damian Plażuk

    Uniwersytet Łódzki, Wydział Chemii

    Call: OPUS 3, Panel: ST5

  13. 113. Modifications of aglycones of leucomycins via Michael addition and Huisgen dipolar cycloaddition as a new routes of synt…

    Principal investigator: dr hab. Piotr Przybylski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

    Call: SONATA BIS 1, Panel: ST5

  14. 114. Identification of amino acid residues located in positions P7 and P8 of model inhibitor of proprotein convertases that d…

    Principal investigator: Izabela Małuch

    Uniwersytet Gdański, Wydział Chemii

    Call: PRELUDIUM 3, Panel: ST5

  15. 115. The influence of metabolic pathway inhibitors on the development and quality of bovine embryos produced in vitro.

    Principal investigator: dr hab. Dorota Marta Cieślak

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

    Call: OPUS 3, Panel: NZ9

  16. 116. Design, synthesis and biological evaluation of Steroid Sulfatase Inhibitors based on organophosphorus compounds.

    Principal investigator: dr Sebastian Demkowicz

    Politechnika Gdańska

    Call: SONATA 2, Panel: NZ7

  17. 117. Synthesis and biological activity evaluation of new hybrid derivatives of tacrine and melatonin as potential cholinester…

    Principal investigator: dr Anna Zawadzka

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 2, Panel: ST5

  18. 118. Function of DNA methylation and CNV-type polymorphisms of genes encoding metalloproteinase and their tissue inhibitors i…

    Principal investigator: dr Edyta Magdalena Majorczyk

    Politechnika Opolska, Wydział Wychowania Fizycznego i Fizjoterapii

    Call: OPUS 2, Panel: NZ5

  19. 119. Comparison of the mechanism of action of valproic acid and levetiracetam as histone deacetylase inhibitors in ovarian ca…

    Principal investigator: Patrycja Katarzyna Kwiecińska

    Uniwersytet Jagielloński, Wydział Biologii i Nauk o Ziemi

    Call: PRELUDIUM 2, Panel: NZ7

  20. 120. Metalloproteinases and tissue inhibitors of metalloproteinases expression in serum and leukocytes in children with prima…

    Principal investigator: dr Joanna Beata Trojanek

    INSTYTUT - POMNIK - CENTRUM ZDROWIA DZIECKA

    Call: OPUS 1, Panel: NZ6

  21. 121. Inhibitors, protein aggregation and carbon nanotube

    Principal investigator: dr hab. Mai Suan Li

    Instytut Fizyki PAN

    Call: OPUS 1, Panel: NZ1

  22. 122. The search for novel human proteasome inhibitors and fluorogenic substrates.

    Principal investigator: dr Dawid Dębowski

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 1, Panel: ST5

  23. 123. RNA chaperone activity of HIV-2 Gag and nuclocapsid proteins: implications for the design of the new retroviral inhibito…

    Principal investigator: dr Katarzyna Pachulska-Wieczorek

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 1, Panel: NZ1

  24. 124. Synthesis and studies of reaction products of oxirane derivatives with the -NH-(C=)-Br functionality of heteroaromatic c…

    Principal investigator: dr Marzena Agnieszka Baran

    Uniwersytet Jagielloński- Collegium Medicum, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: PRELUDIUM 1, Panel: NZ4

  25. 125. Stilbene and stilbazole derivatives as potential cyclooxygenase-2 (COX-2) inhibitors with probable antitumor and chemopr…

    Principal investigator: Miłosz Jakub Regulski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 1, Panel: NZ4

  26. 126. The expression of complement inhibitors in ovarian and corpus uteri cancers - a new perspective for immunotherapy

    Principal investigator: dr hab. Lucyna Kapka-Skrzypczak

    Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Turystyki i Nauk o Zdrowiu

    Call: SONATA 1, Panel: NZ7

  27. 127. Design and synthesis of phosphoroorganic antagonists of BIR domain of apoptosis inhibitor proteins (IAP)

    Principal investigator: dr Agnieszka Łupicka-Słowik

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 7, Panel: ST5

  28. 128. In vitro/in vivo characteristics of hydrophilic matrix containing phosphodiesterase-5 inhibitors.

    Principal investigator: dr Anna Krupa

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 4, Panel: NZ7

  29. 129. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh…

    Principal investigator: Katarzyna Aleksandra Szafrańska

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  30. 130. The role of IFN-γ in inducing phenotype alterations and disulfidptosis in drug-naïve and BRAFV600/MEK inhibitor-resistan…

    Principal investigator: Piotr Wawrzyniak

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM 24, Panel: NZ4

  31. 131. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of…

    Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

    Uniwersytet Mikołaja Kopernika

    Call: PRELUDIUM 24, Panel: ST5

  32. 132. Tick-borne encephalitis virus protease as a molecular target for novel inhibitors and activity-based probes

    Principal investigator: dr Renata Grzywa

    Politechnika Wrocławska

    Call: OPUS 28, Panel: NZ6

  33. 133. Phytochemicals as inhibitors of polylactide's photooxidation and thermooxidation

    Principal investigator: dr Aleksander Mateusz Hejna

    Politechnika Poznańska

    Call: SONATA 20, Panel: ST11

  34. 134. Flozins as potential inhibitors of aortic stenosis progression in patients with concomitant type 2 diabetes: impact on v…

    Principal investigator: dr hab. Joanna Natorska

    Uniwersytet Jagielloński

    Call: OPUS 26, Panel: NZ5

  35. 135. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu…

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

    Call: OPUS 26, Panel: NZ7

  36. 136. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: OPUS 26, Panel: NZ7

  37. 137. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: OPUS 25, Panel: ST4

  38. 138. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  39. 139. The design and development of the peptide inhibitors library targeting Zn(II)-binding site of matrix metalloproteinases …

    Principal investigator: Paulina Alicja Potok

    Uniwersytet Wrocławski, Wydział Chemii

    Call: PRELUDIUM 22, Panel: ST5

  40. 140. Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of …

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: OPUS 21, Panel: NZ7

  41. 141. Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer

    Principal investigator: dr hab. Tomasz Marcin Wróbel

    Uniwersytet Medyczny w Lublinie

    Call: SONATA 16, Panel: NZ7

  42. 142. Structure optimization of the PD-1/PD-L1 inhibitors based on the terphenyl scaffold

    Principal investigator: dr Damian Muszak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 19, Panel: ST4

  43. 143. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  44. 144. Development of a three-dimensional in vitro model for studying the mechanisms of immunostimulatory activity of PD-1/PD-L…

    Principal investigator: Justyna Natalia Kocik-Król

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  45. 145. Multitarget approach to break the vicious circle of tau pathology and neuroinflammation in Alzheimer's disease: developm…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA BIS 9, Panel: NZ7

  46. 146. Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability…

    Principal investigator: Marta Anna Małkiewicz

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

    Call: PRELUDIUM 17, Panel: NZ5

  47. 147. Radiolabelled peptidomimetic inhibitors of the VEGF/NRP-1 complex for imaging of pathological angiogenesis associated wi…

    Principal investigator: prof. Aleksandra Misicka-Kęsik

    Uniwersytet Warszawski

    Call: OPUS 17, Panel: NZ7

  48. 148. Development of new and more efficient treatment against mesothelioma utilizing oncolytic adenovirus armed with ICOS liga…

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

    Call: SONATINA 3, Panel: NZ7

  49. 149. Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth…

    Principal investigator: prof. Ryszard Tomasz Smoleński

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 16, Panel: NZ7

  50. 150. Dual action mode inhibitors of urease and their anti-virulent activity against Helicobacter pylori and Cryptococcus neof…

    Principal investigator: prof. Artur Jacek Mucha

    Politechnika Wrocławska

    Call: OPUS 16, Panel: NZ6

Graphic design and implementation: Jakub Piotrowski